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Intestinal malabsorption i  patients with Cystic Fibrosis (CF) has generally been 
attributed to pancreatic nsufficiency (PI). However, even with adequate pancreatic 
enzyme replacement therapy significant steatorrhea still occurs. The reasons for 
this are unclear, but it has been suggested that CF is associated with mucosal 
inflammation. This may explain the increased incidence of Crohn's disease and a 
five-fold increase of small bowel cancer in this population. 
Aim: To visualize the entire small intestinal mucosa and examine small intestinal 
inflammation i CF patients. 
Methods: CF PI patients without overt evidence of small bowel disease underwent 
Capsule Endoscopy (CE). The images obtained were reviewed by two independent 
physicians. Stool assays of calprotectin, a marker of inflammation were obtained. 
Results: Ten PI patients 18 27 years old with moderate lung disease underwent CE. 
In all patients, small bowel pathology was found. The range of pathology included 
diffuse areas of small bowel inflammation characterized by edema, erythema, 
mucosal breaks, erosions and loss of villi. Calprotectin was increased in all patients. 
Conclusions: These studies show a high prevalence of small intestinal mucosal 
pathology correlating with elevated levels of calprotectin. In the absence of other 
known causes of small bowel pathology it seems likely that the observed amage 
represents a hitherto unknown integral part of the disease, CF Enteropathy. This 
may explain in part the malabsorptive symptoms een in patients with CE 
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2~4] Omeprazole treatment of gastro-esophageal reflux in 
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Background: Gastro-esophageal reflux disease (GERD) is common in Cystic 
Fibrosis (CF). It may cause GI symptoms and respiratory deterioration. Treatment 
with proton inhibitor (PPI) Omeprazole has been shown to improve lung disease 
and decrease symptoms. 
Aim: The aim of this study was to evaluate the presence of acid reflux in patients 
with CF who are treated with standard ose of PPI and have respiratory deterioration 
in spite of antibiotic therapy. 
Methods: We performed 15 repeat 24 h esophageal pH probes on 8 PPI (Omper- 
azole 0.5 mg/kg/day) treated patients (ages 3 19 years) in order to assess whether 
they still suffer from acid reflux. They all had respiratory deterioration which did 
not respond to antibiotic treatment. Their FEV1 was 63±22% of predicted. Only 
3 patients had also GER symptoms and complained of abdominal pain. Initially, 
patients were treated with a standard ose of omeprazole (0.5mg/kg/day); pH 
probe was then performed and the dose was doubled for 1 month if the result 
was pathologic. Significant acid reflux was considered a value of >10% fraction 
time with pH < 4 of the total examination time. pH probing was repeated until 
normal results. 
Results: Under 0.5 mg/kg omeprazole treatment the percent fraction time pH < 4 
was 17.2±17.7 (ranged 3.5 52%). Despite doubling the dose of omeprazole most 
of the patients' results remained pathological nd the fraction time with pH < 4 was 
14.6±11.8 (ranged 5.6 27.8%). In all patients the respiratory deterioration stopped 
and in 4 patients FEV1 improved significantly (from 46.7±11% to 62.8±13.6% of 
predicted). 
Conclusion: Regular doses of omeprazole may not be sufficient to treat CF patients 
with GERD. Repeated 24 h pH probe titrating with increasing dose of omeprazole 
may be needed to achieve efficient reatment. 
• kaparascopic fundoplication is an effective and safe treatment 
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Surgical management of GORD in children has demonstrated fficacy. There is to 
date no published ata in the adult CF population. 
Aim: To describe safety and outcomes in the acute phase following surgical 
treatment of persistent GORD. 
Methods: We retrospectively reviewed all CF patient notes referred for laparoscopic 
reflux surgery between January 1995 and June 2005. Pre surgical variables were 
assessed in the outpatient clinic in the month preceding surgery and post surgical 
variables were assessed at the clinical interface in the month following discharge 
after surgery. 
Results: 20 subjects (10 male) underwent laparoscopic fundoplication (Nissen's 
19, Toupet 1). The median age was 31 years (21 52). Eight patients (36.8%) 
had undergone lung transplantation prior to fundoplication; 12 patients were non- 
transplanted at the time of surgery. Pre-surgical DeMeester scores (off anti-reflux 
treatment) were median 51.5 (range 2.9 234), and Carlsson symptom scores (off 
treatment) ranged from 2 to 18 out of a maximum score of 18. Median change in 
FEV1 for the group was +2% (range 26 to +15%). Median weight change was 
2.1 kg (range: 8.6 to +4.5). Median BMI prior to fundoplication was 20.0 kg/m 2 
(range 16.2~7.3). All patients progressed to a pureed diet within 3 days of 
surgery and received adequate patient controlled parenteral analgesia limited to 
the same period. The majority of subjects were able to discontinue all medical anti- 
reflux treatment following surgery. No significant adverse vents were recorded in 
19 patients, one patient with a progressively declining FEV1 of 20% died 2 weeks 
post-op. 
Conclusions: Laparoscopic fundoplication is an effective and safe treatment for 
GORD in the short term. Long-term efficacy and impacts on lung function and 
nutrition require evaluation. 
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From 1990 and 2005, 42 patients presenting with meconium ileus (MI) secondary 
to cystic fibrosis(CF) were treated in our institution,17 males and 25 females. Nine 
had a family history of CFO (2 of whom also presented with MI). 
Our aim was review the management and outcomes of these patients. 
23 had uncomplicated MI, 17 of which were treated successfully with gastrografin 
enemas (9 requiring two or more enemas). The remaining 6 (2 having perforation 
secondary to enemas) had surgery;enterotomy with anastamosis in 2,appendicec- 
tomy and irrigation in 2 and resection with ileostomy (1), colostomy (1). 
Of the complicated MI (19), 3 had antenatally diagnosed MI with volvulus, MI 
peritonitis and upper intestinal obstruction. 12 had enterotomy with ileostomies 
fashioned, 1 with colostomy. 7 had enterotomy: appendicectomy with irrigation 
in 3, resection and anastamosis in 4. 
Post-operative complications included sepsis (2), respiratory arrest (1), small 
bowel obstruction with re-exploration (3). High output ileostomies (malabsorptive 
diarrhea) were noted in 2 cases. NEC as a late complication (3 and 4 months 
respectively) was noted in two cases. 
Overall survival rate was 100%. 
Molecular genetics were looked at in 39 cases: 7 differing mutations were noted. 29 
were DF508 homozygous, 2 with DF508/621 +IG?T, 2 with DF508/1717 1G?A, 1 
with DF508/G542X, 1 with DF508/R560T, 3 with DF508/2nd mutation ot found 
(+sweat test) and 1 case having P574H and 2623 2A G alterations causing achange 
to the CF gene sequence (mutation ot previously described in an Irish patient). 
Our review compared favourably with those in the literature. Management and 
outcomes of meconium ileus have improved considerably over the past 30 years. 
As we have a very high incidence ° fCF  in Ireland' with 10 15% ofcases presenting 
in the newborn period with MI, medical management of MI is achieved in over 
50% of cases. 100% survival rates are now possible. 
